BALAXI — Balaxi Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Balaxi Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	71.9	282	623	394	146
Net Total Accounts Receivable
Net Total Receivables	318	562	634	1,214	1,461
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,410	1,935	2,102	2,428	2,514
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	60.3	190	171	363	490
Net Goodwill
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,765	2,397	2,583	3,103	3,370
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	633	531	542	545	622
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	633	568	570	786	880
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,132	1,829	2,014	2,317	2,491
Total Liabilities & Shareholders' Equity	1,765	2,397	2,583	3,103	3,370
Total Common Shares Outstanding